13.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Alcoholic Hepatitis Treatment Business (2015-2020)
13.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.3 Author Details
Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis.
The increasing consumption of alcohol worldwide has contributed to the growth of the market. Heavy alcohol consumption causes alcoholic hepatitis, which leads to hepatic encephalopathy. These health conditions have led to high mortality rates. As a result, there is a significant need to treat alcoholic hepatitis. Vendors are using this opportunity to release many treatment options into the market. Many off-label therapies and corticosteroids are available in the market. Off-label therapies are used to treat inflammation in alcoholic hepatitis and corticosteroids are used as first-line treatment. The demand for these drugs will increase because of the lack of curative therapies available in the market.
Market Analysis and Insights: Global Alcoholic Hepatitis Treatment Market
In 2019, the global Alcoholic Hepatitis Treatment market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Alcoholic Hepatitis Treatment Scope and Market Size
Alcoholic Hepatitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Alcoholic Hepatitis Treatment market is segmented into Corticosteroids, Xanthine derivatives, Other, etc.
Segment by Application, the Alcoholic Hepatitis Treatment market is segmented into Hospital, Clinic, Private Treatment Center, etc.
Regional and Country-level Analysis
The Alcoholic Hepatitis Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alcoholic Hepatitis Treatment market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape and Alcoholic Hepatitis Treatment Market Share Analysis
Alcoholic Hepatitis Treatment market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Alcoholic Hepatitis Treatment business, the date to enter into the Alcoholic Hepatitis Treatment market, Alcoholic Hepatitis Treatment product introduction, recent developments, etc.
The major vendors include Apotex Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., etc.
This report focuses on the global Alcoholic Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alcoholic Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Gilead Sciences Inc.
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by Type, the product can be split into
Market segment by Application, split into
Private Treatment Center
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Alcoholic Hepatitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Alcoholic Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Alcoholic Hepatitis Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.